To further investigate whether KIT D816mut/CBFneg AML represents a distinct subtype which is associated with SM and poor prognosis, two independent AML databases (AMLdatabases) were retrospectively screened for KIT D816mut/CBFneg AML patients. Here, KIT is linked to acute myeloid leukemia.